1 / 3

10.00-10.10 Welcome Ole Skøtt

faolan
Télécharger la présentation

10.00-10.10 Welcome Ole Skøtt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Professor Michael Hecht OlsenAppointment SymposiumJanuary 18th. 2012Conference Auditorium U100, Main EntranceUniversity of Southern DenmarkCampusvej 55, 5230 Odense M”Elevated Blood Pressure, Target Organ Damage and Risk Stratification in Relation to Hypertension”1 ECTS pointSupported by an un-restricted grant from Leo PharmaPh.d.-studerende, som ønsker at deltage og modtage 1 ECTS point, skal tilmelde sigper email til Michael Hecht Olsen på mho@dadlnet.dk inden 1/12 2011.

  2. 10.00-10.10 Welcome Ole Skøtt • 10.10-10.40 Prognostic shift of diastolic to systolic blood pressure Julie Vishram Metabolic syndrome - Lack of Prognostic Support Julie Vishram • 10.40-11.10 Prognostic importance of ABPM (non-dipper, BP variability) Tine W. Hansen • 11.10-11.40 Blood pressure goals: The lower the better vs. J-shape Sverre Kjeldsen • 11.40-11.50 Coffee break • 11.50-12.20 The fatal combination of hypertension and diabetes Jan Erik Henriksen • 12.20-12.50 Vascular aging especially in hypertension and diabetes Peter Nilsson • 12.50-13.20 Subclinical large vascular damage (stiffness and central BP) Stéphane Laurent • 13.20-14.20 Light lunch • 14.20-14.50 Subclinical small vascular damage (M/L ratio and CFR) Kent Christensen • 14.50-15.20 Subclinical kidney damage and albuminuria Josep Redon • 15.20-15.50 Subclinical cardiac damage (LVH and LV function) Kristian Wachtell • 15.50-16.05 Nt-proBNP as a marker of LV hypertrophy in SEAS Adam Blyme • 16.05-16.20 Coffee break • 16.20-16.50 Subclinical organ damage in risk stratification Thomas Sehestedt • 16.50-17.20 Nurse driven doctor supervised hypertension clinic Hans Ibsen • 17.20-18.00 Clinic for cardiovascular prevention focusing on hypertension and risk stratification Michael H. Olsen

  3. Professor Ole Skøtt, Dean, Faculty of Health Sciences, The University of Southern Denmark Julie Vishram, PhD student, Cardiovascular Research Unit, Dept. of Internal Medicine, Glostrup Hospital Tine W. Hansen, Senior resident, Department of Nuclear Medicine, Rigshospitalet Professor Sverre Kjeldsen, Chief physician, Department of Cardiology, Ullevaal Hospital, Norway Jan Erik Henriksen, Chief physician, Department of Endocrinology, Odense University Hospital Peter Nilsson,Department of Clinical Sciences Medicine, University Hospital,S-20502 Malmö, Sweden Professor Stéphane Laurent, Pharmacology department, Hopital Europeen Georges Pompidou, Paris, France Kent Christensen, Chief physician, Department of Cardiology, Aarhus University Hospital Professor Josep Redon, Internal Medicine, Hospital Clinico, University of Valencia, 46010 Valencia, Spain Kristian Wachtell, Senior resident, Department of Cardiology, Gentofte Hospital Adam Blyme, PhD student, Cardiovascular Research Unit, Department of Internal Medicine, Glostrup Hospital Thomas Sehestedt, Cardiovascular research Unit, Dept. of Internal Medicine, Glostrup Hospital Professor Hans Ibsen, Chief physician, Hypertension Clinic, Department of Cardiology, Holbæk Hospital Professor Michael H. Olsen, Chief physician, Hypertension Clinic, Dept. of Endocrinology, OUH

More Related